Ebola Deaths in Democratic Republic of Congo Exceed 5,000

Deaths from the Ebola outbreak in the Democratic Republic of Congo have surpassed 5,000, according to government data released in late October 2026. The Congolese Ministry of Health reported 5,026 confirmed deaths out of 10,351 confirmed cases. The case fatality rate stands near 50 percent. Another 2,788 people have recovered. Currently 1,101 people are in treatment or quarantine.

The outbreak was declared on 15 May 2026 and is caused by the Bundibugyo species of the virus. No approved vaccine or specific treatment exists for this strain. Health workers manage patients with supportive care based on symptoms. The World Health Organization declared it a public health emergency of international concern shortly after the declaration. Eight of Congo's 26 provinces have been affected. Fifty of 67 health zones report active cases. The epicenters are Ituri and North Kivu provinces in the east, which account for the large majority of cases and deaths.

This is the second-deadliest Ebola outbreak on record, behind only the 2014-2016 West African epidemic that killed more than 11,000 people across Guinea, Liberia, and Sierra Leone. It is already the deadliest in Congo's history. Delayed detection, ongoing conflict, and strained health services have allowed faster spread than in previous outbreaks. Experts believe the virus may have circulated undetected for months before the official declaration. Many deaths occurred outside treatment centers. The WHO estimates about one-third of deaths happened without any medical care.

Cases have appeared in other countries. Kenya, Uganda, and Nigeria have reported confirmed infections linked to travel from Congo. A Swiss woman who visited Uganda became Nigeria's first case. More than 50 health workers in Congo have died after contracting the virus. Insecurity in eastern provinces has complicated response efforts. A transit center was burned in one incident. Community resistance and violence against responders have occurred in some areas.

Confirmed cases and deaths rose rapidly through the summer and early autumn. The 4,000-death mark was passed in early October. The 5,000 mark followed by late October. Weekly numbers have fluctuated, with some reports of declines in certain zones offset by new geographic spread. The Africa CDC and WHO continue to support surveillance, contact tracing, and treatment centers. Mobile laboratories have been deployed to speed testing.

The absence of a licensed vaccine for Bundibugyo distinguishes this outbreak from recent Zaire ebolavirus events, where ring vaccination was available. Research into candidate vaccines and treatments is underway, but none are approved for use. Infection prevention relies on isolation, personal protective equipment, safe burial practices, and community engagement. The high fatality rate and wide geographic reach have strained existing health infrastructure in affected provinces.

International partners including the European Union, UN agencies, and NGOs have provided funding, personnel, and supplies. Air bridges and expert teams have been activated. Containment remains difficult because of the combination of a novel strain, conflict zones, and population movement. The actual number of infections and deaths is likely higher than confirmed figures because of undetected cases and deaths outside the health system.

Health authorities in neighboring countries have increased screening at borders and airports. The risk of further exportation remains present while transmission continues in Congo. The outbreak has not yet produced large chains of transmission outside the country. Continued support for case management and contact tracing in the eastern provinces is the primary control measure available while vaccine and therapeutic development proceeds.

The 5,000-death threshold marks a significant milestone in an outbreak that has already exceeded all previous Congolese epidemics. Response teams continue operations under difficult security conditions. Updates from the Ministry of Health and international partners will track whether the growth rate stabilizes or continues to rise in the coming weeks.